SCHEMBL3357673

SCHEMBL3357673

CCCCCCCC1CCC(C(=O)Oc2ccc(C=CC(=O)O)cc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.43
ATM Q13315 1/20 0.43
F2 P00734 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
HPGD P15428 2/20 0.40
GAA P10253 1/20 0.40
HTT P42858 2/20 0.40
KMT2A Q03164 2/20 0.40
ELANE P08246 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TP53 P04637 1/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
BCHE P06276 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3357665 1.00 THRB (0.43) THRBATMF2SMN1; SMN2NPC1
SCHEMBL3357812 1.00 THRB (0.43) THRBATMF2SMN1; SMN2NPC1
SCHEMBL3357820 1.00 THRB (0.43) THRBATMF2SMN1; SMN2NPC1
SCHEMBL3356133 1.00 THRB (0.43) THRBATMF2SMN1; SMN2NPC1
SCHEMBL3356143 1.00 THRB (0.43) THRBATMF2SMN1; SMN2NPC1
SCHEMBL3358506 0.99 THRB (0.44) THRBATMF2SMN1; SMN2NPC1
SCHEMBL18406245 0.99 THRB (0.44) THRBATMF2SMN1; SMN2NPC1
SCHEMBL3358513 0.99 THRB (0.44) THRBATMF2SMN1; SMN2NPC1
SCHEMBL25407497 0.96 THRB (0.41) THRBATMF2SMN1; SMN2NPC1
SCHEMBL3356608 0.95 THRB (0.45) THRBATMF2SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208031-B2 Photocrosslinkable materials comprising alicyclic group ROLIC AG (CH) 2019-02-19 US disclosed
EP-2152660-B1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2016-05-11 EP disclosed
US-20100048849-A1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2010-02-25 US disclosed
EP-2152660-A2 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP Rolic AG (CH) 2010-02-17 EP disclosed
WO-2008145225-A2 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2008-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208031-B2 Photocrosslinkable materials comprising alicyclic group DDC, ALAD, DYNC1LI1 THRB 4854/4885ATM 2265/4885F2 963/4885
US-20100048849-A1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP DDC, ALAD, DYNC1LI1 THRB 4854/4885ATM 2265/4885F2 963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.